Baxter International is a US-based company specializing in the fields of pharmaceuticals and medical technology. It was founded in 1931 and is currently active in over 100 countries, with a global network of about 50 manufacturing sites[3].
Baxter offers a wide range of products and therapies used in hospitals and at home. The main areas include:
Baxter's mission is to save and improve lives. The company encourages its employees to develop innovative therapies and products to enhance the quality of life for patients worldwide. Baxter places great importance on diversity, open communication, and interdisciplinary collaboration[1].
Although the provided information does not contain specific sustainability goals from Baxter, the company is committed to making a sustainable contribution to healthcare through its medical innovations. Baxter invests significantly in research and development to create new therapies and technologies that improve the lives of millions of people[3].
In 2023, Baxter announced plans to split into two independent healthcare companies: Baxter and Vantive. Vantive will focus on kidney diseases and vital therapies, while Baxter will continue to be a leading medical technology and pharmaceutical company[2]. This split is intended to further enhance the company's innovation and focus.
